Major technological advances have recently opened up the world of glycans, the most abundant class of biomolecules on Earth. The development of probes using bio-orthogonal chemistry, for which Carolyn Bertozzi was awarded the Nobel Prize in 2022, the development of glycol-arrays and glycomics, and the use of cryo-microscopy to elucidate supramolecular complexes are all cutting-edge approaches that are contributing to the current spectacular boom in Glycoscience.
Due to their structural diversity, glycans represent a veritable biological code that governs controls the fate of cells (migration, interaction, development, etc.) and influences the pathophysiology of all living organisms. The SARS-CoV-2 pandemic has drawn attention to the important role of glycans in host-pathogen relationships and their considerable potential as a therapeutic targets. A detailed understanding of glycan metabolism has thus become a major challenge in understanding the etiology of many pathologies (infections, cancers, inflammation, etc.) and in developing new therapeutic approaches. The emerging field of glyco-drugs opens up the possibility of designing highly specific recombinant antibodies, customised therapeutic proteins, antibiotics to combat multi-drug resistance or chemical chaperones for rare diseases. Finally, dynamic monitoring of glycan expression offers unlimited possibilities for the development of early diagnosis of metabolic, inflammatory, genetic and infectious diseases, with a view to precision medicine.
This two-day symposium will focus on the latest advances in Glycoscience. Our aim is to provide the community interested in human and clinical biology an overview of the latest innovations and concepts in basic glycosciences and their application to biomedicine. This face-to-face conference, open to all, aims to promote the essential translation of Glycoscience into a better understanding of biology. It will also offer a forward-looking view of the discipline and its potential in basic and clinical science.
Organizing committee
Sylvie Fournel-Gigleux, IMoPA, CNRS-Université de Lorraine, Nancy, France
Carine Giovannangeli, Institut thématique Bases moléculaires et structurales du vivant - Inserm, Paris, France
Yann Guerardel, UGSF, CNRS, Université de Lille, France
Anne Imberty, CERMAV - CNRS - Université Grenoble Alpes, France
Hugues Lortat-Jacob, Institut de Biologie Structurale - CNRS - CEA - Université Grenoble Alpes, France
Boris Vauzeilles, ICSN - CNRS - Université Paris-Saclay, France
Invited speakers
Sandrine Belouzard, Center for Infection & Immunity of Lille, Lille, France
Christophe Biot, Glycobiologie Structurale et Fonctionnelle, Université de Lille, Lille, France
Thomas Boltje, Institute for Molecules and Materials, Radboud University, Nijmegen, The Netherlands
Catherine Bui, Ingénierie Moléculaire et Physiopathologie Articulaire, CNRS 7365 - Université de Lorraine, Nancy, France
Isabelle Compagnon, Institut Lumière Matière, Université de Lyon, Lyon, France
Max Crispin, School of Biological Sciences, University of Southampton, Southampton, United Kingdom
Cristina De Castro, Department of Chemical Sciences, University of Napoli Federico II, Napoli, Italy
François Foulquier, Glycobiologie Structurale et Fonctionnelle, Université de Lille, Lille, France
Marcelo Guerin, Institute of Molecular Biology of Barcelona, Barcelona, Spain
Adnan Halim, Copenhagen Center for Glycomics, University of Copenhagen, Copenhagen, Denmark
Anne Harduin, Glycobiologie Structurale et Fonctionnelle, Université de Lille, Lille, France
Laura Hartmann, Institute for Macromolecular Chemistry, University of Freiburg, Freiburg, Germany
Cedric Laguri, Institut de Biologie Structurale, Grenoble, France
Frédérique Lisacek, Proteome Informatics Group, Swiss Institute of Bioinformatics, Geneva, Switzerland
Laurence Mulard, Chimie des biomolecules, Institut Pasteur, Paris, France
Salome Pinho, Faculty of Medicine, University of Porto, Porto, Portugal
Winfried Römer, Faculty of Biology, University of Freiburg, Freiburg, Germany
David Ropartz, Biopolymères Interactions Assemblages, INRAE, Nantes, France
Matthieu Sollogoub, Sorbonne University, Paris, France
Kenichi Suzuki, iGCORE, Gifu University, Gifu, Japan
Rebecca Wild, Institut de Biologie Structurale, Grenoble, France
Manfred Wührer, Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands